![]() |
Volumn 21, Issue 2, 2015, Pages 272-274
|
Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
RIBAVIRIN;
SIMEPREVIR;
SOFOSBUVIR;
ANTIVIRUS AGENT;
FUSED HETEROCYCLIC RINGS;
IMMUNOSUPPRESSIVE AGENT;
SULFONAMIDE;
URIDINE PHOSPHATE;
VIRUS RNA;
ADULT;
ANEMIA;
CASE REPORT;
COMBINATION CHEMOTHERAPY;
DEPRESSION;
FEMALE;
GRAFT RECIPIENT;
HEPATITIS C;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERBILIRUBINEMIA;
LETTER;
LIVER GRAFT;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
PRIORITY JOURNAL;
RECURRENT DISEASE;
VIRUS LOAD;
ANALOGS AND DERIVATIVES;
COMPLICATION;
HEPACIVIRUS;
HIV INFECTIONS;
TREATMENT OUTCOME;
ANTIVIRAL AGENTS;
FEMALE;
HEPACIVIRUS;
HEPATITIS C;
HETEROCYCLIC COMPOUNDS, 3-RING;
HIV INFECTIONS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
RECURRENCE;
RIBAVIRIN;
RNA, VIRAL;
SIMEPREVIR;
SOFOSBUVIR;
SULFONAMIDES;
TREATMENT OUTCOME;
URIDINE MONOPHOSPHATE;
|
EID: 84921792370
PISSN: 15276465
EISSN: 15276473
Source Type: Journal
DOI: 10.1002/lt.24027 Document Type: Letter |
Times cited : (14)
|
References (2)
|